Sfoglia per AUTORE
MARCHETTI M
Collezione ASL Vercelli

  

Items : 28

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. in Journal of hematology & oncology / J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0.

2022
AO Cuneo
ASL Vercelli
ASL Cuneo 1
AOU Alessandria

Ghia P; Stamatopoulos K; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Carrier M; Wróbel T; Segundo LYS; Varettoni M; Visentin A; Vitale C; Vukovic V; Shrestha A; Šimkovi? M; Smirnova S; Špa?ek M; Sportoletti P; Stanca O; Wasik-Szczepanek E; Stavroyianni N; Te Raa D; Tomic K; Tonino S; Trentin L; Van Der Spek E; van Gelder M; et alii...

Selecting ?-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. in HemaSphere / Hemasphere. 2021 Apr 29;5(5):e555. doi: 10.1097/HS9.0000000000000555. eCollection 2021 May.

2021
ASL Asti
ASL Vercelli
AOU San Luigi di Orbassano

Forni GL; Gigante A; Marchetti M; Pinto V; Rigano P; Origa R; Longo F; Graziadei G; De Franceschi L; Casale M; Baronciani D;

COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry in European Heart Journal - Quality of Care and Clinical Outcomes

2021
ASL Torino 4
ASL Vercelli

Pani A; Serdoz R; Politi A; Calcagno S; Granatelli A; Fedele F; Cassin M; Statile D; Donato L; Negro L; Bedogni F; Lo Bianco F; Bechi S; Navazio A; Villella A; Marchese A; Antonelli A; Nassiacos D; Merlino A; Ferrigno C; Antonicelli R; Corrado L; Margheri M; Bonizzato S; Caico SI; Spagnolo D; Corrado VM; Ammirati MA; Merella P; et alii...

Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report. in European journal of haematology / Eur J Haematol. 2020 Oct;105(4):505-507. doi: 10.1111/ejh.13473. Epub 2020 Jul 16.

2020
ASL Asti
ASL Vercelli

Feyles E; Marchetti M; Zinzani P;

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. in Cancer medicine / Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Novara

Vignetti M; Foà R; Ghia P; Cimino G; Cavallari M; Cucci R; de la Serna J; Ferrarini I; Medina Perez A; Mauro FR; Coscia M; Di Raimondo F; Farina L; Molica S; Gaidano G; Doubek M; Ilariucci F; Tedeschi A; Marchetti M; Spacek M; Trentin L; Billio A; Ujjani CS; Roeker L; Orlandi EM; Schuster SJ; Shah NN; Sehgal AR; Pu JJ; et alii...

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.

2020
ASL Biella
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Alessandria

Sonneveld P; Boccadoro M; Larocca A; Musto P; Romano A; Ria R; Giuliani N; Offidani M; Liberati AM; Marchetti M; Mosca-Siez ML; de Fabritiis P; Ballanti S; Monaco F; Gobbi M; Cellini C; Grasso M; Ronconi S; Pescosta N; Petrucci MT; Capra A; Zambello R; Mina R; Di Lullo G; Belotti A;

Second cancers in MPN: Survival analysis from an international study. in American journal of hematology / Am J Hematol. 2020 Mar;95(3):295-301. doi: 10.1002/ajh.25700. Epub 2019 Dec 22.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli

Barbui T; Rambaldi A; Alvarez-Larran A; Vannucchi AM; Griesshammer M; Pane F; De Stefano V; Tieghi A; Isfort S; Recasens V; McMullin MF; Cacciola R; Carli G; Benevolo G; Angona A; Fox ML; Beggiato E; Lunghi F; Wille K; Perez-Encinas M; Rapezzi D; Erez D; Gomez M; Palova M; Casetti IC; Stephenson C; Elli EM; Guglielmelli P; Rumi E; et alii...

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study. in HemaSphere / Hemasphere. 2020 Jun 8;4(3):e395. doi: 10.1097/HS9.0000000000000395. eCollection 2020 Jun.

2020
ASL Asti
ASL Vercelli

Trentin L; Semenzato G; Marasca R; Cuneo A; Luppi M; Bassan R; Krampera M; Marinello S; Piazza F; Gherlinzoni F; Riva M; Briani C; Cibien F; Rigolin GM; Paolini R; Sancetta R; Ferrarini I; Marchetti M; Nasillo V; Visentin A;

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Vannucchi AM; Barbui T; Rambaldi A; Griesshammer M; Alvarez-Larran A; Isfort S; Marchetti M; McMullin MF; Tieghi A; Recasens V; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Lunghi F; Angona A; Wille K; Perez-Encinas M; Erez D; Gomez M; Rapezzi D; Palova M; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; et alii...

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Foà R; Marasca R; Laurenti L; Trentin L; Mauro FR; Gattei V; Ibatici A; Rigolin GM; Orsucci L; Pietrasanta D; Re F; Marchetti M; De Paoli L; Varettoni M; Quaglia FM; Reda G; Scarfò L; Cuneo A;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Gattei V; Foà R; Massaia M; Gaidano G; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Magliulo D; Rossi D; Marchetti M; Bonello L; Pozzato G; Bo MD; Kopecka J; Bomben R; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V; Coscia M;

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. in Leukemia / Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

De Stefano V; Marchetti M; Vannucchi AM; Ghirardi A; Barbui T;

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. in Leukemia research / Leuk Res. 2019 Jun;81:88-94. doi: 10.1016/j.leukres.2019.04.016. Epub 2019 May 2.

2019
ASL Asti
ASL Vercelli

Tura S; Pane F; Marchetti M; Girmenia C; Gaidano G; Zinzani PL; Rambaldi A; Barosi G;

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. in Leukemia / Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.

2019
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli

Vannucchi AM; Alvarez-Larran A; Griesshammer M; Recasens V; Marchetti M; Tieghi A; McMullin MF; Cacciola R; Carli G; Benevolo G; Fox ML; Beggiato E; Perez-Encinas M; Lunghi F; Angona A; Wille K; Gomez M; Bertolotti L; Erez D; Palova M; Elli EM; Guglielmelli P; Casetti IC; Stephenson C; Patriarca A; Rumi E; Scaffidi L; Bonifacio M; Delaini F; et alii...

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

2018
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Beggiato E; Pugliese N; Elli EM; Martinelli V; Palumbo GA; Cilloni D; Ferrero D; Crisà E;

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.

2018
ASL Asti
ASL Vercelli

Kroeger N; Finazzi G; Bacigalupo A; Marchetti M; Koschmieder S; Hasselbalch HC; Harrison C; Mc Mullin MF; Cervantes F; Reiter A; Hehlmann R; Kiladjian JJ; Mesa R; Verstovsek S; Hoffman R; Silver RT; Passamonti F; Vannucchi AM; Tefferi A; Barbui T; Griesshammer M; Birgegard G; Barosi G;

Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review. in American journal of hematology / Am J Hematol. 2018 May;93(5):698-703. doi: 10.1002/ajh.25049. Epub 2018 Feb 10.

2018
ASL Asti
ASL Vercelli

Barbui T; Capitoni E; Carobbio A; Marchetti M;

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Eyre TA; Kennedy B; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Re F; Gaidano G; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Amendola A; Billio A; Visco C; Mauro FR; Galieni P; Orlandi EM; Farina L; Delgado AR; Musuraca G; Laurenti L; Coscia M; Perez AM; et alii...

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. in Blood / Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.

2018
ASL Asti
ASL Vercelli

Fazi P; Marchetti M; Salvi F; Mauro FR; Lucchini E; Farina M; D'Adda M; Binda F; Fattizzo B; Paoloni F; Gramegna D; Rossi G; Zaja F; Barcellini W;

Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):469-480. doi: 10.1080/14737167.2017.1366858. Ep

2017
ASL Asti
ASL Vercelli

Marchetti M;

Identification of new BMP6 pro-peptide mutations in patients with iron overload. in American journal of hematology / Am J Hematol. 2017 Jun;92(6):562-568. doi: 10.1002/ajh.24730. Epub 2017 Apr 29.

2017
ASL Asti
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Vercelli

Girelli D; Delledonne M; Olivieri O; Giorgetti A; Suku E; Xumerle L; Roetto A; Marchetti M; De Gobbi M; Badar S; Busti F; Rizzi M; Marchi G; Castagna A; Piubelli C;

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.

2017
ASL Asti
ASL Vercelli

Passamonti F; McMullin MF; Kröger N; Kiladjian JJ; Hehlmann R; Harrison C; Griesshammer M; Birgegård G; Cervantes F; Barosi G; Marchetti M; Vannucchi A; Barbui T;

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):221-35. doi: 10.1586/14737167.2016.1147351. Epub 20

2016
ASL Asti
ASL Vercelli

Marchetti M; Liberato NL;

Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):75-85. doi: 10.1016/j.clml.2014.07.002. Epub 2014 Jul 15.

2015
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Vercelli

Vitolo U; Rambaldi A; Marchetti M; Billio A; Barosi G; Baldini L; Arcaini L; Tarella C; Zinzani PL; Tura S;

Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. in Cytotherapy / Cytotherapy. 2014 Jan;16(1):101-10. doi: 10.1016/j.jcyt.2013.07.001. Epub 2013 Oct 26.

2014
ASL Asti
ASL Vercelli

Gotti E; Dal Pozzo S; Marchetti M; Mancini S; Pandolfi A; Risso M; Perseghin P; Bosi A; Accorsi P; Introna M; Pierelli L; Olivieri J; Rambaldi A; Leoni P; Olivieri A;

Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):815-24. doi: 10.1586/14737167.2014.957682. Epub

2014
ASL Asti
ASL Vercelli

Marchetti M; Liberato NL;

Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease. in The European journal of health economics : HEPAC : health economics in prevention and care / Eur J Health Econ. 2013 Dec;14(6):853-61. doi: 10.1007/s10198-012-0430-7. Epub 2012 Sep 14.

2013
ASL Asti
ASL Vercelli

Liberato NL; Marchetti M; Di Sabatino A; Corazza GR;

Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment. in Infection / Infection. 2011 Aug;39(4):375-8. doi: 10.1007/s15010-011-0109-5. Epub 2011 May 3.

2011
ASL Asti
ASL Vercelli

Marchetti M; Zallio F; Casabianca A; Feyles E; Concialdi E; Ferroglio E; Biglino A;